1.Gaillard Y, Krishnamoorthy A, Bevalot F. Cerbera odollam: a “suicide tree” and cause of death in the state of Kerala, India. J Ethnopharmacol. 2004; 95:123–6.
2. Cerbera odollam. Available from: https://lkcnhm.nus.edu.sg/dna/organisms/details/302 Accessed August 11, 2019
3. Flora Fauna Web. [cited 2019 Nov 12]. Available from: https://florafaunaweb.nparks.gov.sg/Special-Pages/plantdetail.aspx?id=2800 Accessed August 11, 2019
4. Menezes RG, Usman MS, Hussain SA, Madadin M, Siddiqi TJ, Fatima H, et al. Cerbera odollam toxicity: A review. J Forensic Leg Med. 2018; 58:113–6.
5. Severson E, Jufer-Phipps R, Fowler DR, Alexander R. Beyond the Boundaries of Forensic Toxicology - the Use of an Atypical Consultant in a Rare Case of Cerberin Poisonin. Academic Forensic Pathology. 2015; 5:140–4.
6. Kassop D, Donovan MS, Cohee BM, Mabe DL, Wedam EF, Atwood JE. An unusual case of cardiac glycoside toxicity. Int J Cardiol. 2014;170: 434–7.
7. Eddleston M, Haggalla S. Fatal injury in eastern Sri Lanka, with special reference to cardenolide self-poisoning with Cerbera manghas fruits. Clin Toxicol. 2008; 46:745–8.
8. Carlier J, Guitton J, Bévalot F, Fanton L, Gaillard Y. The principal toxic glycosidic steroids in Cerbera manghas L. seeds: Identification of cerberin, neriifolin, tanghinin and deacetyltanghinin by UHPLC–HRMS/MS, quantification by UHPLC–PDA-MS. Journal of Chromatography B. 2014; 962:1–8.
9. Cheenpracha S, Karalai C, Rat-A-Pa Y, Ponglimanont C, Chantrapromma K. New cytotoxic cardenolide glycoside from the seeds of Cerbera manghas. Chem Pharm Bull. 2004; 52:1023–5.
10. Prassas I, Diamandis EP. Novel therapeutic applications of cardiac glycosides. Nat Rev Drug Discov. 2008; 11:926–35.
11. Nelson LS, Hoffman RS, Howland MA, Lewin NA, Goldfrank LR. Goldfrank’s Toxicologic Emergencies, Eleventh Edition. McGraw Hill Professional; 2018.
12. Wermuth ME, Vohra R, Bowman N, Furbee RB, Rusyniak DE. Cardiac Toxicity from Intentional Ingestion of Pong-Pong Seeds (Cerbera Odollam). J Emerg Med. 2018; 55:507–11.
13. Menon MS, Kumar P, Jayachandran CI. Clinical Profile and Management of Poisoning with Suicide Tree: An Observational Study. Heart Views. 2016; 17:136–9.
14. Roberts DM, Gallapatthy G, Dunuwille A, Chan BS. Pharmacological treatment of cardiac glycoside poisoning. British Journal of Clinical Pharmacology. 2016; 81:488–95.
15. Khajja BS, Sharma M, Singh R. Forensic Study of Indian Toxicological Plants as Botanical Weapon (BW): A Review. Journal of Environmental & Analytical Toxicology. 2011; 1: 112.
16. Radford DJ, Cheung K, Urech R, Gollogly JR, Duffy P. __________ 127 Immunological detection of cardiac glycosides in plants. Aust Vet J. 1994; 71:236–8.
17. Laphookhieo S, Cheenpracha S, Karalai C, Chantrapromma S, Rat-a-Pa Y, Ponglimanont C, et al. Cytotoxic cardenolide glycoside from the seeds of Cerbera odollam. Phytochemistry. 2004; 65: 507–10.
18. Maillaud C, Lefebvre S, Sebat C, Barguil Y, Cabalion P, Cheze M, et al. Double lethal coconut crab (Birgus latro L.) poisoning. Toxicon. 2010; 55:81–6.
19. Laizure SC, Herring V, Hu Z, Witbrodt K, Parker RB. The role of human carboxylesterases in drug metabolism: have we overlooked their importance? Pharmacotherapy. 2013; 33:210– 22.
20. Renymol B, Palappallil D, Ambili N. Study on clinical profile and predictors of mortality in Cerbera odollam poisoning. Indian J Crit Care Med. 2018; 22:431–4.
21. Bismuth C, Gaultier M, Conso F, Efthymiou ML. Hyperkalemia in Acute Digitalis Poisoning: Prognostic Significance and Therapeutic implications. Clinical Toxicology. 1973; 6: 153–62.
22. Antman EM, Wenger TL, Butler VP Jr, Haber E, Smith TW. Treatment of 150 cases of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments. Final report of a multicenter study. Circulation. 1990; 81:1744–52.
23. Woolf AD, Wenger T, Smith TW, Lovejoy FH Jr. The Use of Digoxin-Specific Fab Fragments for Severe Digitalis Intoxication in Children. N Engl J Med. 1992; 326:1739–44.
24. Roberts DM, Buckley NA. Antidotes for acute cardenolide (cardiac glycoside) poisoning. Cochrane Database Syst Rev . 2006; 4:CD005490. Available from: http://dx.doi.org/10.1002/14651858.CD005490.pub2. Accessed August 1, 2019.
25. Rajapakse S. Management of yellow oleander poisoning. Clin Toxicol. 2009; 47:206–12.
26. Cheung K, Urech R, Taylor L, Duffy P, Radford D. Plant cardiac glycosides and digoxin Fab antibody. J Paediatr Child Health. 1991; 27:312–3.
27. Roberts DM, Southcott E, Potter JM, Roberts MS, Eddleston M, Buckley NA. Pharmacokinetics of digoxin cross-reacting substances in patients with acute yellow Oleander (Thevetia peruviana) poisoning, including the effect of activated charcoal. Ther Drug Monit. 2006; 28:784–92.
28. Lip GY, Metcalfe MJ, Dunn FG. Diagnosis and treatment of digoxin toxicity. Postgrad Med J. 1993; 69:337–9. Available from: http://pmj.bmj.com/cgi/doi/10.1136/pgmj.69.811.337 Accessed August 15, 2019
29. de Silva HA, Fonseka MMD, Pathmeswaran A. Multiple-dose activated charcoal for treatment of yellow oleander poisoning: a single-blind, randomised, placebo-controlled trial. Lancet. 2003; 361:1935–8.
30. American Academy of Clinical Toxicology, European Association of Poisons Centres and Clinical Toxicologists. Position Statement and Practice Guidelines on the Use of Multi-Dose Activated Charcoal in the Treatment of Acute Poisoning. J Toxicol Clin Toxicol. 1999; 37:731–51.
31. Eddleston M, Juszczak E, Buckley NA, et al. Multiple-dose activated charcoal in acute self-poisoning: a randomised controlled trial. Lancet. 2008; 371:579–87.
32. Dasgupta A, Emerson L. Neutralization of cardiac toxins oleandrin, oleandrigenin, bufalin, and cinobufotalin by digibind: Monitoring the effect by measuring free digitoxin concentrations. Life Sciences. 1998; 63:781–8.
33. Bandara V, Weinstein SA, White J, Eddleston M. A review of the natural history, toxinology, diagnosis and clinical management of Nerium oleander (common oleander) and _________ CONCLUSION REFERENCES 128 A Fatal Case of Suicide Fruit Ingestion in Singapore by Cerbera cardiac Glycoside intoxication Y. Lee et al. Thevetia peruviana (yellow oleander) poisoning. Toxicon. 2010; 56:273–81.
34. Levine M, Nikkanen H, Pallin DJ. The effects of intravenous calcium in patients with digoxin toxicity. J Emerg Med. 2011; 40:41–6.
35. Hack JB, Woody JH, Lewis DE, Brewer K, Meggs WJ. The Effect of Calcium Chloride in Treating Hyperkalemia Due to Acute Digoxin Toxicity in a Porcine Model. Journal of Toxicology: Clinical Toxicology. 2004; 42:337–42.
36. Muller SH, Diaz JH, Kaye AD. Clinical applications of intravenous lipid emulsion therapy. J Anesth. 2015; 29:920–6.
37. Weinberg G. Lipid Rescue Resuscitation from Local Anaesthetic Cardiac Toxicity. Toxicol Rev. 2006; 25:139–45.
38. Yurtlu BS, Özbilgin Ş, Yurtlu DA, et al. Intravenous lipid emulsion prolongs survival in rats intoxicated with digoxin. Am J Emerg Med. 2016; 34:1112–6.
39. Bejarovski NG Lipid Rescue Therapy and High-Dose Insulin Euglycemic Therapy are Effective for Severe Refractory Calcium Channel Blocker Overdose: Case Report and Review of Literature. Asia Pac J Med Toxicol. 2013; 2(3): 114-116.
40. Mir SA & Rasool R Reversal Of Cardiovascular Toxicity in Severe Organophosphate Poisoning with 20% Intralipid Emulsion Therapy: Case Report and Review of Literature. Asia Pac J Med Toxicol. 2014; 3: 169-72.
41. Mowry JB, Burdmann EA, Anseeuw K, Ayoub P, Ghannoum M, Hoffman RS, et al. Extracorporeal treatment for digoxin poisoning: systematic review and recommendations from the EXTRIP Workgroup. Clin Toxicol. 2016; 54:103–14.
42. Nissenson AR, Fine RE. Handbook of Dialysis Therapy 5th ed. Elsevier, 2016;1143.
43. Wang GS, Levitan R, Wiegand TJ, Lowry J, Schult RF, Yin S, et al Extracorporeal Membrane Oxygenation (ECMO) for Severe Toxicological Exposures: Review of the Toxicology Investigators Consortium (ToxIC). J Med Toxicol. 2016; 12:95–9.
44. Kim Z, Goldfarb D, S: Continuous Renal Replacement Therapy Does Not Have a Clear Role in the Treatment of Poisoning. Nephron Clin Pract 2010;115:c1-c6. doi: 10.1159/000286343
45. Wang GS, Levitan R, Wiegand TJ, Lowry J, Schult RF, Yin S, et al. Extracorporeal Membrane Oxygenation (ECMO) for Severe Toxicological Exposures: Review of the Toxicology Investigators Consortium (ToxIC). Journal of Medical Toxicology. 2016 Mar 1;12(1):95–9. Doi: 10.1007/s13181- 015-0486-8
46. Lewis, J., Zarate, M., Tran, S Albertson T.The Recommendation and Use of Extracorporeal Membrane Oxygenation (ECMO) in Cases Reported to the California Poison Control System. J. Med. Toxicol. 15, 169–177 (2019). https://doi.org/10.1007/s13181-019-00704-3